NIFR Image-guided Surgery for Malignant Soft Tissue Tumor With Low-dose SWIG Technique

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

592

Participants

Timeline

Start Date

October 30, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

December 30, 2030

Conditions
Dermatofibrosarcoma Protuberans (DFSP)Skin Squamous Cell Carcinoma
Interventions
DRUG

ICG administration

The ICG was injected intravenously 24 hours before surgery at a dose of 0.25 mg/kg in the first experimental group.

DRUG

ICG administration

The ICG was injected intravenously 24 hours before surgery at a dose of 25 mg/patient in the second experimental group.

DRUG

ICG administration

The ICG was injected intravenously 24 hours before surgery at a dose of 0.25 mg/kg in the first experimental group

DRUG

ICG administration

The ICG was injected intravenously 24 hours before surgery at a dose of 25 mg/patient in the second experimental group.

All Listed Sponsors
collaborator

1、 Department of Plastic and Reconstructive Surgery, Peking University Third Hospital

UNKNOWN

collaborator

2、 Department of Plastic and Reconstructive Surgery, 1st Medical Center of Chinese PLA General Hospital

UNKNOWN

collaborator

3、 Department of Plastic and Reconstructive Surgery, Peking University International Hospital

UNKNOWN

lead

The Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

OTHER

NCT06610071 - NIFR Image-guided Surgery for Malignant Soft Tissue Tumor With Low-dose SWIG Technique | Biotech Hunter | Biotech Hunter